Holen Sie sich die Stockscreener-App
33.42
2.14%
0.70
Handel nachbörslich:
35.00
1.58
+4.73%
Schlusskurs vom Vortag:
$32.72
Offen:
$32.6
24-Stunden-Volumen:
339.43K
Relative Volume:
0.96
Marktkapitalisierung:
$1.06B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
-90.32
EPS:
-0.37
Netto-Cashflow:
$274.29M
1W Leistung:
-5.16%
1M Leistung:
-20.16%
6M Leistung:
-10.90%
1J Leistung:
+50.54%
1-Tages-Spanne:
$32.52
$33.53
1-Wochen-Bereich:
$32.52
$35.62
52-Wochen-Spanne:
$21.40
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Collegium Pharmaceutical is Now Oversold (COLL) - Nasdaq
Emerald Advisers LLC Acquires 177,129 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.60 Average Target Price from Analysts - Defense World
(COLL) Trading Report - Stock Traders Daily
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Collegium Pharmaceutical (COLL) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Allspring Global Investments Holdings LLC Has $3.08 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Assenagon Asset Management S.A. Sells 188,423 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - MSN
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? - MSN
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - Simply Wall St
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com - MarketBeat
StockNews.com Downgrades Collegium Pharmaceutical (NASDAQ:COLL) to Buy - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript - MSN
(COLL) Investment Report - Stock Traders Daily
Inspire Investing LLC Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by StockNews.com - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Short Interest Down 6.5% in September - MarketBeat
Sanctuary Advisors LLC Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Receives Neutral Rating from Piper Sandler - Defense World
SG Americas Securities LLC Has $707,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Given "Neutral" Rating at Piper Sandler - MarketBeat
Collegium Pharmaceutical Inc [COLL] Records 50-Day SMA of $37.25 - Knox Daily
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - Yahoo Finance
Market Update: Collegium Pharmaceutical Inc (COLL) Sees Negative Movement, Closing at 36.64 - The Dwinnex
Collegium Pharmaceutical And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
(COLL) Investment Analysis - Stock Traders Daily
Millennium Management LLC Has $9.79 Million Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Keeping an Eye on Collegium Pharmaceutical Inc (COLL) After Insider Trading Activity - Knox Daily
70,964 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Acquired by Marshall Wace LLP - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by ProShare Advisors LLC - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Marshall Wace LLP Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Collegium Pharmaceutical stock hits all-time high of $41.04 By Investing.com - Investing.com Canada
Breakouts Boost These Three Stocks To All-Time Highs - Investor's Business Daily
Collegium Pharmaceutical (NASDAQ:COLL) Reaches New 12-Month HighTime to Buy? - MarketBeat
Collegium Pharmaceutical stock hits all-time high of $41.04 - Investing.com
Axa S.A. Takes Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) delivers shareholders solid 28% CAGR over 5 years, surging 5.1% in the last week alone - Simply Wall St
A new trading data show Collegium Pharmaceutical Inc (COLL) is showing positive returns. - SETE News
H.C. Wainwright’s latest rating for COLL stock - Knox Daily
Squarepoint Ops LLC Has $3.55 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Squarepoint Ops LLC Has $3.55 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Hsbc Holdings PLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Deerfield Management Company L.P. Series C Has $428,000 Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Maverick Capital Ltd. Has $1.28 Million Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Should We Be Delighted With Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 46%? - Yahoo Finance
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):